05/31/2024 3:30 PM | Inhibrx Biosciences, Inc. (Issuer) Inhibrx (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:22 PM | Inhibrx (Issuer) Lappe Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:23 PM | Inhibrx (Issuer) MANHARD KIMBERLY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:23 PM | Inhibrx (Issuer) Vuori Kristiina MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:21 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:21 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:22 PM | FORSYTH DOUGLAS (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/30/2024 5:22 PM | Inhibrx (Issuer) Kayyem Jon Faiz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:32 PM | Inhibrx (Filer)
| Form POSASR | |
05/30/2024 3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 7:39 AM | Inhibrx (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/28/2024 3:55 PM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 5:15 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:44 PM | Inhibrx Biosciences, Inc. (Issuer) Inhibrx (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/22/2024 8:54 AM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 8:48 PM | Inhibrx (Filer)
| Form DEFA14A | |
05/17/2024 4:29 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:42 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:36 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 3:22 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024 3:54 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 2:56 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 3:36 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:50 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:46 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:48 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:22 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 10:34 AM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:04 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 3:20 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 2:28 PM | Deck Kelly (Reporting) Inhibrx (Subject) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:41 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 1:58 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:26 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:26 PM | Inhibrx (Filer)
| Form PREM14A | |
02/28/2024 8:10 AM | Inhibrx (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 8:12 AM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
02/06/2024 3:30 PM | Inhibrx (Filer)
| Form DEFA14A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Inhibrx (Subject)
| Form SC 13G/A | |
01/23/2024 4:25 PM | Inhibrx (Filer)
| Form DEFA14A | |
01/23/2024 9:10 AM | Inhibrx (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024 5:35 AM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 5:38 AM | Inhibrx (Filer)
| Form DEFA14A | |
11/02/2023 8:16 AM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2023 7:44 PM | HALVORSEN OLE ANDREAS (Reporting) Inhibrx (Issuer) Ott David C. (Reporting) Shabet Rose Sharon (Reporting) VIKING GLOBAL INVESTORS LP (Reporting) Viking Global Opportunities GP LLC (Reporting) Viking Global Opportunities Parent GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 8:03 AM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |